Effectiveness of lipid-lowering therapy with statins for secondary prevention of atherosclerosis-- guidelines vs. reality. Pharmacol Rep. 2012;64(2):377-85.Boz_entowicz-Wikarek M, Kocełak P, Smertka M, et al. Effectiveness of lipid-lowering therapy with statins for secondary prevention of ...
However, leveraging the surgical encounter to improve adherence to statin guidelines requires an understanding of the patterns of underuse specific to this population. The primary aim of this manuscript was thus to describe the prevalence of statin underuse for secondary prevention of ASCVD among ...
Statins for Secondary Stroke Prevention in Patients without Known Coronary Heart Disease: The Jury Is Still Out Statins for Secondary Stroke Prevention in Patients without Known Coronary Heart Disease: The Jury Is Still Outhigh altitudeacute mountain sickness... LB Goldstein,P Amarenco,J Bogousslav...
Use of statins in the secondary prevention of coronary heart disease: is treatment equitable? To investigate possible inequities in the use of statins for people with coronary heart disease according to a wide range of social and clinical factors. D... FDA Reid,DG Cook,PH Whincup - 《Heart》...
Aspirin Strategy for Secondary Prevention of Atherosclerotic Cardiovascular Diseases: A Narrative Review Aspirin is the most used antiplatelet agent for secondary prophylaxis of atherosclerotic cardiovascular diseases. Individual variability in aspirin respons... N Hegde,N Mathew - 《Journal of the Practice ...
Roger S. Blumenthal, MD:From a primary prevention point of view, the moderate-intensity statins are probably what most clinicians think about starting, whether that is 10 mg or 20 mg of atorvastatin or 20 mg or 40 mg of simvastatin. For secondary prevention (the higher-risk individuals), we...
According to evidence from clinical trials demonstrating effectiveness and safety, statins are widely recommended for the primary and secondary prevention of cardiovascular diseases4 and have been included in WHO clinical practice guidelines for cardiovascular disease prevention and control since 2007.5 In ...
Statins: new American guidelines for prevention of cardiovascular disease. Lancet. 2013;382(9907):1762-1765.PubMedGoogle ScholarCrossref 8. Lloyd-Jones DM, Goff D, Stone NJ. Statins, risk assessment, and the new American prevention guidelines. Lancet. 2014;383(9917):600-602.PubMedGoogle ...
Previous studies have shown that statin therapy is generally cost-effective for secondary prevention and for high-risk primary prevention of heart disease in specific scenarios, but have not previously analyzed the full impact or cost-effectiveness of NCEP guidelines, nor compared them to alternatives....
year period.Atorvastatin (40%) and simvastatin (39%) were the most commonly used.Conclusions In China,statins are still underused for secondary prevention among survivors of ischemic stroke.Reasons for this poor use need to be understood in order to increase use of these evidence based therapies....